Literature DB >> 34321252

Acquired Decline in Ultrafiltration in Peritoneal Dialysis: The Role of Glucose.

Raymond T Krediet1.   

Abstract

Ultrafiltration is essential in peritoneal dialysis (PD) for maintenance of euvolemia, making ultrafiltration insufficiency-preferably called ultrafiltration failure-an important complication. The mechanisms of ultrafiltration and ultrafiltration failure are more complex than generally assumed, especially after long-term treatment. Initially, ultrafiltration failure is mainly explained by a large number of perfused peritoneal microvessels, leading to a rapid decline of the crystalloid osmotic gradient, thereby decreasing aquaporin-mediated free water transport. The contribution of peritoneal interstitial tissue to ultrafiltration failure is limited during the first few years of PD, but becomes more important in long-term PD due to the development of interstitial fibrosis, which mainly consists of myofibroblasts. A dual hypothesis has been developed to explain why the continuous exposure of peritoneal tissues to the extremely high dialysate glucose concentrations causes progressive ultrafiltration decline. First, glucose absorption causes an increase of the intracellular NADH/NAD+ ratio, also called pseudohypoxia. Intracellular hypoxia stimulates myofibroblasts to produce profibrotic and angiogenetic factors, and the glucose transporter GLUT-1. Second, the increased GLUT-1 expression by myofibroblasts increases glucose uptake in these cells, leading to a reduction of the osmotic gradient for ultrafiltration. Reduction of peritoneal glucose exposure to prevent this vicious circle is essential for high-quality, long-term PD.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  free water transport; glucose transporters; hypoxia; myofibroblasts; osmolality; peritoneal dialysis; pseudohypoxia; small pore fluid transport; ultrafiltration insufficiency

Mesh:

Substances:

Year:  2021        PMID: 34321252      PMCID: PMC8722789          DOI: 10.1681/ASN.2021010080

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   14.978


  61 in total

1.  Morphologic changes in the peritoneal membrane of patients with renal disease.

Authors:  John D Williams; Kathrine J Craig; Nicholas Topley; Christopher Von Ruhland; Maureen Fallon; Geoffrey R Newman; Ruth K Mackenzie; Geraint T Williams
Journal:  J Am Soc Nephrol       Date:  2002-02       Impact factor: 10.121

2.  Day-to-day variability of fluid and solute transport in upright and recumbent positions during CAPD.

Authors:  A L Imholz; G C Koomen; W J Voorn; D G Struijk; L Arisz; R T Krediet
Journal:  Nephrol Dial Transplant       Date:  1998-01       Impact factor: 5.992

3.  Peritoneal vasculopathy in the pathophysiology of long-term ultrafiltration failure: A hypothesis based on clinical observations
.

Authors:  Raymond T Krediet; Anouk T N van Diepen; Annemieke M Coester; Dirk G Struijk
Journal:  Clin Nephrol       Date:  2019-01       Impact factor: 0.975

4.  Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis.

Authors:  M A Mateijsen; A C van der Wal; P M Hendriks; M M Zweers; J Mulder; D G Struijk; R T Krediet
Journal:  Perit Dial Int       Date:  1999 Nov-Dec       Impact factor: 1.756

5.  Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.

Authors:  Luiz S Aroeira; Abelardo Aguilera; Rafael Selgas; Marta Ramírez-Huesca; M Luisa Pérez-Lozano; Antonio Cirugeda; M Auxiliadora Bajo; Gloria del Peso; José A Sánchez-Tomero; José A Jiménez-Heffernan; Manuel López-Cabrera
Journal:  Am J Kidney Dis       Date:  2005-11       Impact factor: 8.860

6.  A three-pore model of peritoneal transport.

Authors:  B Rippe
Journal:  Perit Dial Int       Date:  1993       Impact factor: 1.756

7.  Regulation of glucose transporters in human peritoneal mesothelial cells.

Authors:  Michael Fischereder; Bernd Schröppel; Patrick Wiese; Monika Fink; Bernhard Banas; Stefan Schmidbauer; Detlef Schlöndorff
Journal:  J Nephrol       Date:  2003 Jan-Feb       Impact factor: 3.902

8.  Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study.

Authors:  R Selgas; M J Fernandez-Reyes; E Bosque; M A Bajo; F Borrego; C Jimenez; G Del Peso; F De Alvaro
Journal:  Am J Kidney Dis       Date:  1994-01       Impact factor: 8.860

Review 9.  The hallmarks of mitochondrial dysfunction in chronic kidney disease.

Authors:  Daniel L Galvan; Nathanael H Green; Farhad R Danesh
Journal:  Kidney Int       Date:  2017-11       Impact factor: 10.612

10.  Role of pseudohypoxia in the pathogenesis of type 2 diabetes.

Authors:  Jing Song; Xiaojuan Yang; Liang-Jun Yan
Journal:  Hypoxia (Auckl)       Date:  2019-06-05
View more
  7 in total

1.  Phloretin Improves Ultrafiltration and Reduces Glucose Absorption during Peritoneal Dialysis in Rats.

Authors:  Karin Bergling; Giedre Martus; Carl Oberg
Journal:  J Am Soc Nephrol       Date:  2022-08-19       Impact factor: 14.978

Review 2.  Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis.

Authors:  Valentina Masola; Mario Bonomini; Silvio Borrelli; Lorenzo Di Liberato; Luigi Vecchi; Maurizio Onisto; Giovanni Gambaro; Roberto Palumbo; Arduino Arduini
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

Review 3.  Relative Contributions of Pseudohypoxia and Inflammation to Peritoneal Alterations with Long-Term Peritoneal Dialysis Patients.

Authors:  Raymond T Krediet; Alena Parikova
Journal:  Clin J Am Soc Nephrol       Date:  2022-02-15       Impact factor: 10.614

Review 4.  Aging of the Peritoneal Dialysis Membrane.

Authors:  Raymond T Krediet
Journal:  Front Physiol       Date:  2022-04-28       Impact factor: 4.755

5.  Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy.

Authors:  Rusan Ali Catar; Maria Bartosova; Edyta Kawka; Lei Chen; Iva Marinovic; Conghui Zhang; Hongfan Zhao; Dashan Wu; Daniel Zickler; Honorata Stadnik; Marek Karczewski; Julian Kamhieh-Milz; Achim Jörres; Guido Moll; Claus Peter Schmitt; Janusz Witowski
Journal:  Front Immunol       Date:  2022-02-04       Impact factor: 7.561

6.  High intraperitoneal interleukin-6 levels predict ultrafiltration (UF) insufficiency in peritoneal dialysis patients: A prospective cohort study.

Authors:  Qianhui Song; Xiaoxiao Yang; Yuanyuan Shi; Hao Yan; Zanzhe Yu; Zhenyuan Li; Jiangzi Yuan; Zhaohui Ni; Leyi Gu; Wei Fang
Journal:  Front Med (Lausanne)       Date:  2022-08-10

7.  Angiotensin II type 2 receptor prevents extracellular matrix accumulation in human peritoneal mesothelial cell by ameliorating lipid disorder via LOX-1 suppression.

Authors:  Jing Liu; Bo Jin; Jian Lu; Yuan Feng; Nan Li; Cheng Wan; Qing-Yan Zhang; Chun-Ming Jiang
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.